Affinity Investment Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,125
| Closed | -$207K | – | 170 |
|
|
2023
Q4 | $207K | Sell |
6,125
-3,620
| -37% | -$122K | 0.14% | 171 |
|
|
2023
Q3 | $299K | Hold |
9,745
| – | – | 0.19% | 156 |
|
|
2023
Q2 | $390K | Sell |
9,745
-1,965
| -17% | -$78.7K | 0.23% | 149 |
|
|
2023
Q1 | $478K | Hold |
11,710
| – | – | 0.26% | 141 |
|
|
2022
Q4 | $452K | Buy |
11,710
+99
| +0.9% | +$3.82K | 0.21% | 149 |
|
|
2022
Q3 | $618K | Hold |
11,611
| – | – | 0.32% | 113 |
|
|
2022
Q2 | $677K | Sell |
11,611
-640
| -5% | -$37.3K | 0.33% | 105 |
|
|
2022
Q1 | $935K | Sell |
12,251
-3,385
| -22% | -$258K | 0.38% | 93 |
|
|
2021
Q4 | $941K | Buy |
15,636
+77
| +0.5% | +$4.63K | 0.38% | 99 |
|
|
2021
Q3 | $871K | Hold |
15,559
| – | – | 0.39% | 90 |
|
|
2021
Q2 | $944K | Hold |
15,559
| – | – | 0.43% | 86 |
|
|
2021
Q1 | $1.09M | Sell |
15,559
-950
| -6% | -$66.6K | 0.4% | 71 |
|
|
2020
Q4 | $988K | Sell |
16,509
-410
| -2% | -$24.5K | 0.4% | 66 |
|
|
2020
Q3 | $1.02M | Sell |
16,919
-370
| -2% | -$22.2K | 0.45% | 60 |
|
|
2020
Q2 | $907K | Hold |
17,289
| – | – | 0.43% | 63 |
|
|
2020
Q1 | $580K | Buy |
17,289
+5,570
| +48% | +$187K | 0.3% | 72 |
|
|
2019
Q4 | $531K | Hold |
11,719
| – | – | 0.19% | 87 |
|
|
2019
Q3 | $446K | Hold |
11,719
| – | – | 0.14% | 95 |
|
|
2019
Q2 | $510K | Buy |
+11,719
| New | +$510K | 0.15% | 82 |
|